Alex Marson is a professor at UCSF and the director of the Gladstone-UCSF Institute of Genomic Immunology. He trained under the joint mentorship of Rick Young and Rudolf Jaenisch at the Whitehead Institute at MIT for his PhD. He completed medical school, internship, and residency at the Brigham and Women’s Hospital in Boston and started his lab as a Sandler Faculty Fellow at UCSF in 2013. In addition to his positions at UCSF and the Gladstone-UCSF Institute of Genomic Immunology, he is the scientific director of human health at the Innovative Genomics Institute, a member of the Parker Institute for Cancer Immunotherapy, and an investigator at the Chan Zuckerberg Biohub. His research is focused on adapting CRISPR genome-editing techniques to human immune cells in order to understand the genetic programs controlling immune cell function and to manipulate T cells to generate cell-based therapies for a wide range of diseases.
On November 3, 2021, researchers from the Gladstone-UCSF Institute of Genomic Immunology discussed how they are using their diverse expertise in a rapidly advancing field to design and produce tailored immune cell therapies to combat a broad array of diseases.